Pfizer sharply increased its 2021 projection for revenues tied to its Covid-19 vaccine and also lifted its full-year profit outlook. AFP
Pfizer sharply increased its 2021 projection for revenues tied to its Covid-19 vaccine and also lifted its full-year profit outlook. AFP
Pfizer’s profit surges 59% on strong Covid-19 vaccine sales
The Covid-19 shot made by Pfizer and its German partner BioNTech drew in sales worth $7.8bn in the second quarter
